Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hyperemia

• Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma
• Natriuresis-guided Depletion After Cardiac Surgery
• Therapeutic Strategies to Reduce Endothelial Ischemia-reperfusion Injury
• Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome
• Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss
• Ssafety and Tolerability of PRO-185
• Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia
• Curcumin and Exercise in Chronic Kidney Disease
• PORH and Response to Cold in Raynaud's Phenomenon.
• Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes
• Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.
• Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants
• Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness
• Role of Epoxy-eicosatrienoic Acids in Post-occlusive Hyperemia and Thermal Hyperemia
• Comparison of Intravenous Adenosine Infusion With Regadenoson Bolus for Inducing Maximal Coronary Hyperemia
• A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension
• Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole
• Effect of Polymorphisms in the Adenosine a2a Receptor Gene and AMPD2 Gene on Adenosine-Induced Vasodilation and Reactive Hyperemia